Advertisement

Search Results for "Marvelon In China"

13:16 EDT 19th May 2013 | BioPortfolio

Original Source: A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception

The purpose of this study is to evaluate the effectiveness in terms of prevention of pregnancy and safety of the oral contraceptive Yasmin and Marvelon on cycle control in healthy Chinese women

Matching Channels

China

China has the fastest growing economy in the world, and the fastest growing uptake of technology in the world. Not surprisingly, its biotechnology industry is booming. Its potential not only as a pr...

H7N9 Bird Flu Virus

Avian influenza A H7 viruses are a group of influenza viruses that normally circulate among birds. The avian influenza A(H7N9) virus is one subgroup among the larger group of H7 viruses. Although so...

College Hill - international business communications consultancy

College Hill is a growing international business communications consultancy with offices in Europe, China, India, South Africa and the United States. College Hill's wide range of complementar...

Alternative Medicine - news, reports, trials and publications

Traditional Chinese Medicine (simplified Chinese: 中医; traditional Chinese: 中醫; pinyin: zhōng yī: "Chinese Medicine") refers to a broad range of medicine practices sharing common...

Cardiovascular

Cardiovascular diseases (CVD) are the world’s most serious disease, killing 17.1 million people a year. CVDs are a group of disorders affecting the heart and blood vessels.  The most...

Matching News

China – a huge opportunity but where to start?

Flic Gabbay explores the pharmaceutical business opportunities in China in our R&D innovation focus month. “Everybody knows they must be in China – but few know why they must be in China,”...

Device MNCs In China Call For Procurement Visibility And Standardization

In its 2012 “American Business in China White Paper,” AmCham China proposed to China measures regarding imported medical device prices.

Takeda North Asia SVP Haruhiko Hirate On The Fundamentals Of Building A China Business: An Interview With PharmAsia News

As China changes over the years, the experienced China hand is now tasked with revitalizing the Japanese pharma’s presence in China to gain ground on its Western peers.

CPhI China to be held in Shanghai from June 26 to 28

CPhI China, dedicated exhibition for the medical & pharmaceutical industrymwill be held from June 26 to 28 at the SNIEC in Shanghai. CPhI China and ICSE China for contract and outsourced services, wil...

2012 BIO Convention in China: Highlighting Cross-Border Partnering in Biotechnology

In its second year, the BIO Convention in China will be held October 24-25, 2012 in Shanghai, China. BIO China will bring together executives from biotechnology, pharmaceutical companies and investmen...

China to Grant India Greater Access to its Pharma Market

China agreed to give India greater access to its markets for pharma, agriculture and IT products. India has been upset with China because only $18 billion of products flows from India to China, whil...

Great China Mania Artists as Spokesman for Bossini China, Hong Kong, Singapore and China

HONG KONG, April 12, 2013 (GLOBE NEWSWIRE) -- Great China Mania Holdings, Inc., (OTCBB:GMEC) (the "Company" or "GMEC") announces its most famous artists Chrissie becomes the Spokesman for Bossini (SE...

Multinationals Accelerate China Localization In 2012

More and more companies are building R&D and manufacturing facilities in China for China, and many are expanding outside of traditional locations like Shanghai and Beijing.

Matching PubMed Articles

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement